focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Virgin Wines warns sales will be below City forecasts

Thu, 04th May 2023 19:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Virgin Wines UK PLC - Norwich, England-based online wine retailer - Expects financial year 2023 sales to be slightly lower than market expectations, at around GBP60 million, with underlying pretax profit in the region of GBP500,000 to GBP1 million, with a profitable and cash generative fourth quarter. Thereafter, expects double digit sales growth in financial year 2024, alongside an earnings before interest, tax, depreciation and amortisation margin of around 4% to 5%, as inflationary pressures particularly on freight and glass start to ease. Reports fourth quarter trading is expected to be in line with the previous year, but adds the third quarter was affected by a reduction in order frequency through the WineBank customer membership, a period which saw an increasingly competitive environment. Encouragingly, points out cancellation and conversion rates have started to improve since the end of the first half whilst the trade rate has also recovered from its low point in November 2022.

----------

Pollen Street PLC - London, England-based asset manager - Reports net asset value at March 31 was 900 pence or GBP578 million while its tangible net asset value per share was 540p or GBP347 million. No comparison given. Says assets under management remained at GBP3.4 billion while average fee-paying AUM continued to build to GBP2.5 billion in the first quarter, up from GBP2.3 billion for 2022. Declares a dividend of 16p.

----------

Hansard Global PLC - Isle of Man-based long-term savings provider - Issues trading update for the third quarter to March 31. Says new business was GBP25.4 million, ahead of GBP18.6 million in the previous quarter and down from GBP31.4 million a year prior. Assets under administration were GBP1.12 billion, up GBP15.6 million from the end of December. Continues to make encouraging progress with distribution opportunities for its Japanese proposition, company states. Adds new business in its largest region, Middle East and Africa, rose 20.8%, while in Latin America new business was down 9.5%.

----------

Forward Partners Group PLC - London-based early-stage technology-focused investor - Reports revenue in the year to December 31 of GBP509,000 down from GBP826,000 a year prior with a pretax loss of GBP43.1 million compared to a profit of GBP16.5 million. Net asset value at period end was 72 pence down from 104p a year before. Remains confident that healthy returns can be generated from the investment in early-stage UK startups over the long-term.

----------

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Reports pretax loss in the year to January 31 of GBP9.8 million widened from GBP9.5 million a year before on broadly unchanged revenue of GBP475,000 compared to GBP477,000. Basic and diluted earnings per share was 1.54 pence compared to 1.65p. Says well-positioned to advance pipeline of first-in-class preclinical RNAi candidates across multiple therapeutic areas, making significant progress in just one year. Notes increased losses mainly attributable to increased R&D expenditure reflecting further progress and development of its business strategy. Explains company has sufficient funds to continue in operational existence for at least 12 months from the signing of these financial statements.

----------

Let's Explore Group PLC - Manchester, England-based virtual reality entertainment company, formerly called Immotion Group PLC - Reports pretax loss from continuing operations in the year to December 31 of GBP1.9 million widened from GBP1.8 million on reduced revenue of GBP796,000, down from GBP2.5 million. Basic loss per share totalled 0.46 pence compared to 0.43p a year prior. Says group revenue from total operations increased 23% to GBP11.6 million from GBP9.4 million while adjusted earnings before interest, tax, depreciation and amortisation from total operations rose 51% to GBP1.4 million from GBP0.9 million. Notes since the year end the group has sold its largest business, Location Based Entertainment for around USD25 million and a smaller subsidiary, Uvisan.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
21 May 2015 08:23

e-Therapeutics Says First Patient Enrolled In Phase Ib ETS2101 Trial

Read more
31 Mar 2015 08:21

e-Therapeutics Loss Widens As It Increases Development Spending

Read more
26 Feb 2015 14:12

e-Therapeutics Believes Drug Discovery Process Producing Higher Yield

Read more
23 Jan 2015 13:36

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

Read more
21 Jan 2015 11:42

DIRECTOR DEALINGS: e-Therapeutics Finance Director Buys 150,000 Shares

Read more
16 Oct 2014 07:40

E-Therapeutics Appoints Sean Nicholson As Executive Director

Read more
16 Sep 2014 09:08

e-Therapeutics Loss Widens On Pipeline Development; Chair To Retire

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
4 Jul 2014 16:30

Daily Mail General Trust's Chairman sells £15.91m-worth of shares

Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or

Read more
4 Jul 2014 08:59

DIRECTOR DEALINGS: e-Therapeutics Finance Chief Buys 100,000 Shares

Read more
25 Jun 2014 16:02

DIRECTOR DEALINGS: e-Therapeutics Non-Executives Allotted New Shares

Read more
12 May 2014 11:49

e-Therapeutics Loss Widens As It Continues Pipeline Development

LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e

Read more
8 May 2014 13:30

UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures

LONDON (Alliance News) - British gas parent Centrica has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians

Read more
8 May 2014 12:23

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.